Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 1 1

Status

Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 2

Conditions

Uterine Cervical Neoplasms 1Meningeal Neoplasms 1Gynecologic Cancer 1

Interventions

Magnetic Resonance Spectroscopy 270Specimen Handling 259pembrolizumab 235Cyclophosphamide 220Radiotherapy 208Nivolumab 171Cisplatin 162Carboplatin 150Biopsy 148Radiosurgery 130fludarabine 125Blood Specimen Collection 117Gemcitabine 113Paclitaxel 111Surveys and Questionnaires 109Standard of Care 106venetoclax 97Dexamethasone 96Bevacizumab 95Radiation 88Rituximab 84Capecitabine 82Cytarabine 79Oxaliplatin 77Doxorubicin 76Drug Therapy 75durvalumab 73Ipilimumab 72fludarabine phosphate 69atezolizumab 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × gadobutrol × 90 days × Clear all
NCT04219904 2026-05-20

PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
25 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT07415018 2026-04-14

Optimizing Contrast Dose and Scanning Parameters for Detection of Leptomeningeal Disease

M.D. Anderson Cancer Center

Phase NA Not yet recruiting
40 enrolled

Meningeal Neoplasms

NCT04893434 2026-04-02

Novel Imaging Technique to Assess Gynecologic Cancer

Memorial Sloan Kettering Cancer Center

Phase 1 Active not recruiting
24 enrolled
Gynecologic

Gynecologic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡